-
RELATION NAME
-
RELATION NAME
-
RELATION NAME
-
[4] Abe H., Umeda T., Kawai Y., Tanaka M., Mori T., Cho H., et al., [Adjuvant trastuzumab can be infused safely over 30 minutes], Gan To Kagaku Ryoho, 2010, 37, 1887–1891
-
RELATION NAME
-
RELATION NAME
-
RELATION NAME
-
RELATION NAME
-
[9] Nagahisa Y., Imai S., Yamaguchi K., Okabe M., Tsuruta A., Kawamoto K., et al., [A case of liver metastasis of breast cancer responding to trastuzumab plus weekly paclitaxel chemotherapy maintaining CR for 30 months], Gan To Kagaku Ryoho, 2007, 34, 1501–1503
-
[10] Horiguchi J., Oyama T., Takata D., Rokutanda N., Nagaoka R., Odawara H., et al., Pathological complete response and prognosis in patients receiving neoadjuvant paclitaxel and trastuzumab with and without anthracyclines for stage II and III, HER2-positive operable breast cancer: a single-institute experience, Anticancer Res., 2011, 31, 3041–3046